Search Clinical Studies

Search results for All Clinical Studies.

Found 258 clinical studies.

• Observation For Severe Hemolytic Anemia Of The Fetus

  • Investigator: Kara Markham
  • Posted Date: Jun 14, 2019
  • Type of Study: Observational/Survey

• The Value Of Gut Microbiota In Pulmonary Arterial Hypertension

  • Investigator: Arun Jose
  • Posted Date: Jun 13, 2019
  • Type of Study: Observational/Survey

• A Pilot Study To Evaluate The Efficacy And Safety Of Budesonide As An Alternative To Prednisone For Liver Transplant Immune Suppression

  • Investigator: Khurram Bari
  • Posted Date: Jun 13, 2019
  • Type of Study: Drug

• Respiratory Tract Microbiome In Children

  • Investigator: Tiina Reponen
  • Posted Date: Jun 12, 2019
  • Type of Study: Observational/Survey

• Non-Invasive Spinal Stimulation For The Treatment Of Major Depression

  • Investigator: Francisco Romo-Nava
  • Posted Date: Jun 12, 2019
  • Type of Study: Device

• A Randomized, Placebo-Controlled Study Of Liraglutide 3Mg Daily (Saxenda®) In Obese Or Overweight Patients With Stable Bipolar Disorder

  • Investigator: Susan Lynn Mcelroy
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• Invasive Bedside Procedures: Determining Competence And Skill Decay Over Time

  • Investigator: Dana Sall
  • Posted Date: Jun 12, 2019
  • Type of Study: Observational/Survey

• A Double-Blind, Placebo-Controlled, Randomized To Evaluate Valbenazine For The Treatment Of Tardive Dyskinesia

  • Investigator: Susan Lynn Mcelroy
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• Breast Sensation After Breast Reconstruction

  • Investigator: Elizabeth Dale
  • Posted Date: Jun 12, 2019
  • Type of Study: Observational/Survey

• A Phase 1/2, Multicenter Study Of Nktr-262/Nktr-214 With Or Without Nivolumab In Patients With Multiple Solid Tumors

  • Investigator: Shuchi Gulati
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101

  • Investigator: Brian Moseley
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• Ucci-Hem-17-01

  • Investigator: Tahir Latif
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• D6070c00005

  • Investigator: Olugbenga Olowokure
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• Clinical Outcomes In Endocrine Disease

  • Investigator: Tammy Holm
  • Posted Date: Jun 11, 2019
  • Type of Study: Observational/Survey

• Bio-Data-16-01

  • Investigator: Thomas Herzog
  • Posted Date: Jun 11, 2019
  • Type of Study: Device

• Screening For Aids-Hiv Clinical Studies

  • Investigator: Carl Fichtenbaum
  • Posted Date: Jun 11, 2019
  • Type of Study: Observational/Survey

• Child And Adolescent Study For Bipolar Disorder - Manic Or Mixed Episodes

  • Investigator: Melissa Delbello
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• First In Human Study Of Broadly Neutralizing Antibodies To Control Hiv

  • Investigator: Carl Fichtenbaum
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• Eaf151

  • Investigator: Rekha Chaudhary
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• 19244

  • Investigator: Olugbenga Olowokure
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• The Purpose Of This Study Is To Evaluate The Safety And Efficacy Of A Study Medication In Adults With Depression.

  • Investigator: Lesley Arnold
  • Posted Date: Jun 11, 2019
  • Type of Study: Drug

• Eovist

  • Investigator: Sadhna Verma
  • Posted Date: Jun 10, 2019
  • Type of Study: Device

• Nrg-Gy004

  • Investigator: Thomas Herzog
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Sweat Production And Seizure Detection

  • Investigator: Brian Moseley
  • Posted Date: Jun 10, 2019
  • Type of Study: Device

• Ea8143

  • Investigator: Abhinav Sidana
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Alliance A221505

  • Investigator: Teresa Meier
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Tesaro 3000-01-002

  • Investigator: Muhammad Riaz
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Nrg-Gy006

  • Investigator: Thomas Herzog
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Gog0261

  • Investigator: Thomas Herzog
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Raphael Aml003

  • Investigator: Zartash Gul
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• 2015-7950R

  • Investigator: Sadhna Verma
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Cg01-Gbm

  • Investigator: Nicholas Marko
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Incyte Incb 39110-301

  • Investigator: Zartash Gul
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Measuring Unbound Parathyroid Hormone Levels In Blood And Saliva

  • Investigator: Alice Tang
  • Posted Date: Jun 10, 2019
  • Type of Study: Device

• Isa Therapeutics Isa101b-Hn-01-17

  • Investigator: Muhammad Riaz
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Randomized Controlled Trial Of Immediate Versus Delayed Cochlear Implantation Hearing Loss In Older Adults Study

  • Investigator: Ravi Samy
  • Posted Date: Jun 10, 2019
  • Type of Study: Device

• Ea1151

  • Investigator: Lawrence Sobel
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Gog0258

  • Investigator: Thomas Herzog
  • Posted Date: Jun 10, 2019
  • Type of Study: Drug

• Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?

  • Investigator: David Steward
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Donation Of Excised Keloid And Hypertrophic Scar Tissue For Use In Research Studies

  • Investigator: Dorothy Supp
  • Posted Date: Jun 10, 2019
  • Type of Study: Observational/Survey

• Myk-461-005 (Explorer-Hcm): A Randomized, Double-Blind, Placebo-Controlled Clinical Study To Evaluate Mavacamten (Myk-461) In Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

  • Investigator: Richard Becker
  • Posted Date: Jun 9, 2019
  • Type of Study: Drug

• Prevalence Of Emergency Department Opioid Exposure And Previous Use Of Opioids And Other Substances In An Urban Emergency Department Population

  • Investigator: Edmond Hooker
  • Posted Date: Jun 7, 2019
  • Type of Study: Observational/Survey

• Computed Tomographic Quantification Of Periaortic Adipose Tissue Volume As A Correlate Of Cardiovascular Disease

  • Investigator: Edmond Hooker
  • Posted Date: Jun 7, 2019
  • Type of Study: Observational/Survey

• A Prospective Registry For Patients Treated With Proton Therapy

  • Investigator: John Breneman
  • Posted Date: Jun 7, 2019
  • Type of Study: Observational/Survey

• Use Of Molindone For The Treatment Of Impulsive Aggression In Children And Adolescents With Adhd

  • Investigator: Caleb Adler
  • Posted Date: Jun 7, 2019
  • Type of Study: Drug

• Migraine Research Study

  • Investigator: Lesley Arnold
  • Posted Date: Jun 7, 2019
  • Type of Study: Drug

• Abdominal Pain In The Emergency Department

  • Investigator: Edmond Hooker
  • Posted Date: Jun 7, 2019
  • Type of Study: Observational/Survey

• Novel Contrast Enhanced Mri Protocol For Detecting Small Brain Tumor

  • Investigator: Jinghua Wang
  • Posted Date: Jun 6, 2019
  • Type of Study: Device

• The Ed-Sed Study: A Multicenter, Prospective Cohort Study Of Practice Patterns And Clinical Outcomes Associated With Emergency Department Sedation For Mechanically Ventilated Patients

  • Investigator: William Knight
  • Posted Date: Jun 6, 2019
  • Type of Study: Observational/Survey

• General Blood Draw To Help Develop Ways To Break Up Blood Clots

  • Investigator: Christy Holland
  • Posted Date: Jun 6, 2019
  • Type of Study: Device & Drug

• Optimizing Magnetic Resonance Imaging Acquisitions For Brain Imaging

  • Investigator: Jinghua Wang
  • Posted Date: Jun 6, 2019
  • Type of Study: Device

• Chest Wall Injury Database

  • Investigator: Christopher Janowak
  • Posted Date: Jun 6, 2019
  • Type of Study: Observational/Survey

• Assess Safety And Efficacy Of Agents Targeting Dna Damage Repair With Olaparib Versus Olaparib Only In Stage Iv Triple-Negative Breast Cancer (Tnbc) Patients

  • Investigator: Neetu Radhakrishnan
  • Posted Date: Jun 4, 2019
  • Type of Study: Drug

• Utilization Of Adjuvant Chemotherapy In Patients With Pathologic Complete Response In Rectal Cancer

  • Investigator: Ian Paquette
  • Posted Date: May 29, 2019
  • Type of Study: Observational/Survey

• A Study To Determine If Radiotherapy Given In Fewer Visits Is Possible In Patients With Recurrent Diffuse Intrinsic Pontine Glioma

  • Investigator: Luke Pater
  • Posted Date: May 29, 2019
  • Type of Study: Observational/Survey

• Once-Daily Tacrolimus In Patients Undergoing Kidney Transplantation And Steroid Withdrawal

  • Investigator: Simon Tremblay
  • Posted Date: May 24, 2019
  • Type of Study: Drug

• Value Of Baseline Cardiac Magnetic Resonance Imaging For Predicting Adverse Outcomes In Treatment-Naïve Pulmonary Hypertension Patients

  • Investigator: Arun Jose
  • Posted Date: May 23, 2019
  • Type of Study: Observational/Survey

• Ship- A Randomized, Placebo-Controlled Pilot Study Of Sulfasalazine For The Treatment Of Primary Sclerosing Cholangitis

  • Investigator: Kenneth Sherman
  • Posted Date: May 23, 2019
  • Type of Study: Drug

• Subcutaneous Pain Medication To Provide Faster Pain Relief During A Sickle Cell Crisis

  • Investigator: Caroline Freiermuth
  • Posted Date: May 23, 2019
  • Type of Study: Observational/Survey

• Epidemiology Of Subdural Hematomas At The University Of Cincinnati Medical Center

  • Investigator: David Robinson
  • Posted Date: May 22, 2019
  • Type of Study: Observational/Survey

• A Phase II Study Of Combination Of Pd-L1 Inhibitor Durvalumab With Cetuximab In Metastatic And Recurrent Head And Neck Squamous Cell Carcinoma

  • Investigator: Shuchi Gulati
  • Posted Date: May 20, 2019
  • Type of Study: Drug

• Subjects With Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vegfr-Targeted Therapy

  • Investigator: David Steward
  • Posted Date: May 17, 2019
  • Type of Study: Drug

• Healthy Goal Achievement Through Action Planning And Lifestyle Management After Stroke Intervention (Healthy Goals): An Efficacy Study.

  • Investigator: Valerie Hill
  • Posted Date: May 15, 2019
  • Type of Study: Device

• Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trial (Alchemist)

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + Tak-700 With Androgen Deprivation Therapy + Bicalutamide In Patients With Newly

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Trial To Validate Medication Adherence Monitoring Using Facial Recognition And Motion Sensing Technology For Patients Receiving Sublingual Buprenorphi

  • Investigator: Theresa Winhusen
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Emergency Contraceptive Study For Females Weighing 176 Pounds Or More Who Have Recently Had Unprotected Intercourse.

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Irb# 2017-5650 Testing An Investigational Product In Bleeding Thrombocytopenic Patients.

  • Investigator: Jose Cancelas-Perez
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Study Evaluating The Impact Of Serum-Derived Bovine Immunoglobulin Protein Isolate

  • Investigator: Carl Fichtenbaum
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III, Open-Label, Randomized Study Of Atezolizumab (Mpdl3280a, Anti-Pd-L1 Antibody) In Combination With Carboplatin Paclitaxel With Or Without

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Standard Epidural Steroid Injection With Supplemental Oral Medicine For Low Back Pain For

  • Investigator: Harsh Sachdeva
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Rapastinel As An Added Therapy In Major Depressive Disorder

  • Investigator: Erik Nelson
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Elios

  • Investigator: Jeffrey Sussman
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Do You Have A Child With Attention/Hyperactivity Problems And Are Seeking Alternatives To Medication?

  • Investigator: Robert Mcnamara
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Trial Comparing High Dose Interferon To Mk-3475 (Pembrolizumab) In Patients With High Risk Resected Melanoma.

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Individualized Treatment For Nasopharyngeal Cancer Based On The Patient?S Dna

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Dasotraline For Children With Adhd

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• An Open-Label, Single-Arm Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Early Stage Relapsing Remitting Multiple Scle

  • Investigator: Lawrence Goldstick
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Placebo Controlled Phase 2B/3 Study Of Abt-414 With Concurrent Chemoradiation And Adjuvant Temozolomide In Subjects With Newly Diagnosed

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Double Blind, Multicenter, Parallel-Group, Phase III Study To Evaluate Efficacy And Safety Of Dcvac/Pca Versus Placebo In Men With Metas

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter Phase 1/2B Study Of The Bruton?S Tyrosine Kinase Inhibitor, Ibrutinib (Pci-32765), In Combination With Carfilzomib (Kyprolis?) In Subjec

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ea2165

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Testing The Effect Of Adding Abiraterone Acetate And Enzalutamide To Metastatic Hormone Refractory Prostate Cancer, When Compared To Enzalutamide Alon

  • Investigator: Nilesh Patil
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• D5660c00004

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Niche Trial: Stroke Recovery Therapy Using Brain Stimulation

  • Investigator: Kari Dunning
  • Posted Date: May 15, 2019
  • Type of Study: Device

• A Randomized Phase III Trial Of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed By Weekly Paclitaxel With Or Without Carboplat

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Prospective Study Of Magnetic Resonance Imaging (Mri) And Multiparameter Gene Expression Assay In Ductal Carcinoma In Situ (Dcis)

  • Investigator: Neetu Radhakrishnan
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II Randomized Controlled Trial Of Genomically Directed Therapy After Preoperative Chemotherapy In Patients With Triple Negative Breast Cance

  • Investigator: Neetu Radhakrishnan
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A 2-Year, Multi-Center, Phase II, Open-Label, Fixed-Dose, Randomized Comparative Trial Of Azacitidine, With Or Without Deferasirox In Patients With Hi

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II/III Study Of Image-Guided Radiosurgery/Sbrt For Localized Spine Metastasis

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II Single-Arm Trial To Investigate Tepotinib In Stage IIIb/Iv Adenocarcinoma Of The Lung With Met Exon 14 (Metex14) Skipping Alterations After

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase III Trial Evaluating The Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (Ct1-3 N1) Who Have Positive Sentinel Lym

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractionated Radiation Therapy For Borderline Resectable Adenocarcinoma Of The Head Of Th

  • Investigator: Syed Ahmad
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Testing An Investigational Drug With Standard Treatment Before Surgery For Rectal Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III, Open-Label, Randomized Study To Investigate The Efficacy And Safety Of Atezolizumab (Anti?Pd L1 Antibody) Compared With Best Supportive C

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2 Evaluation Of Trc105 In Combination With Bevacizumab For The Treatment Of Recurrent Or Progresisve Gliblastoma That Has Progressed On Bevaci

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study Of An Investigational Drug For The Treatment Of Generalized Anxiety Disorder (Gad)

  • Investigator: Jeffrey Strawn
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Adults With Posttraumatic Stress Disorder (Ptsd)

  • Investigator: Kathleen Chard
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Phase II Investigation Of Adjuvant Combined Cisplatin And Radiation With Pembrolizumab In Resected Hnscc

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Testing The Addition Of Hormonal Therapy To Usual Chemotherapy In Advanced Breast Cancer

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase III Trial Of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles Of Docetaxel Plus Cyclophosphamide Or Four Cycles Of Doxorub

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase I Open-Label Study To Evaluate The Effect Of Multiple Doses Of Azd1775 On The Pharmacokinetics Of Substrates For Cyp3a, Cyp2c19, Cyp1a2 And To

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II Open Label Study Of Lenalidomide R-Chop (R2chop) Vs Rchop (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) I

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Exceptional Responders Pilot Study: Molecular Profiling Of Tumors From Cancer Patients Who Are Exceptional Responders

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Enroll-Hd

  • Investigator: Andrew Duker
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase III Trial Evaluating Both Erlotinib And Chemoradiation As Adjuvant Treatment For Patients With Resected Head Of Pancreas Adenocarcinoma

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2 Randomized Study Of Efatutazone, An Oral Ppar Agonist, In Combination With Paclitaxel Versus Paclitaxel In Patients With Advanced Anaplasti

  • Investigator: Muhammad Riaz
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 1 Multicenter, Open-Label, Dose-Escalation And Dose-Expansion Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Immunogenicity, An

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• International Prospective Database At The Hub

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Phase II Trial Of Smo/Akt/Nf2 Inhibitors In Progressive Meningiomas With Smo/Akt/Nf2 Mutations

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Trial Of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus S

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Adjuvant Nivolumab In Resected Lung Cancers (Anvil) A Randomized Phase III Study Of Nivolumab After Surgical Resection And Adjuvant Chemotherapy In N

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2, Multicenter, Open-Label Study Of Ds-8201A, An Anti-Her2-Antibody Drug Conjugate (Adc) For Her2-Positive, Unresectable And/Or Metastatic Bre

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Examining Medical School Communication Curriculum At Medical Universities

  • Investigator: Melissa Carroll
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Pilot Study: Extended Regional Anesthesia To Prevent Chronic Pain After Ankle Fracture Surgery

  • Investigator: Jun-Ming Zhang
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase 1, Two-Part, Multicenter, Non-Randomized, Open-Label, Multiple Dose First-In-Human Study Of Ds-8201A, In Patients With Advanced Solid Malignant

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase III Trial Of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy In Hpv-Associated Oropharynx Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Double-Blind Phase 3 Trial Comparing Vintafolide (Ec145) And Pegylated Liposomal Doxorubicin (Pld/Doxil?/Caelyx?) In Combination Versus P

  • Investigator: Eric Eisenhauer
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Novel Biomarker Study In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme (Gbm)

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Do You Suffer From Frequent Aches And Pains? Do You Have Fibromyalgia?

  • Investigator: Lesley Arnold
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II Study Of Irinotecan And Cetuximab With Or Without Vemurafenib In Braf Mutant Metastatic Colorectal Cancer.

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Please Contact The Coordinator For More Information.

  • Investigator: Lawrence Goldstick
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 0/1 Exploratory Pharmacokinetic And Pharmacodynamics Study Of Letrozole In Combination With Standard Therapy In Recurrent Gliomas

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II Trial Of Concurrent Chemoradiotherapy +/- Metformin Hcl In Locally Advanced Nsclc

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• An Investigation Of Molecular Markers, Metabolism, And The Immune System Compared To Clinical Outcomes In Cancer Patients And Normal Healthy Controls:

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Trial Of Chemotherapy With Or Without Bevacizumab In Patients With Recurrent Or Metastatic Head And Neck Cancer

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 3 Randomized, Multicenter, Multinational, Double-Blinded Study Comparing The Efficacy And Safety Of Repeated Biweekly Infusions Of Neogaa (Gz4

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2 Study To Evaluate The Safety And Effect Of Study Drug On Proteinuria In Subjects With Iga Nephropathy, Lupus Nephritis, Membranous Nephropa

  • Investigator: Mahmoud El-Khatib
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Intergroup Randomized Phase II Four Arm Study In Patients = 60 With Previously Untreated Mantle Cell Lymphoma

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter Open-Label Phase 1B/2 Study Of The Bruton?S Tyrosine (Btk) Inhibitor, Ibrutinib, In Combination With Lenalidomide And Rituximab In Subje

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase II Pilot Study Prospectively Evaluating Treatment For Patients Based On Ercc1 (Excision Repair Cross-Complementing 1) For Advanced/

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Adults With Posttraumatic Stress Disorder (Ptsd) Needed For Research Study

  • Investigator: Kathleen Chard
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Randomized Phase II Study Of Pre-Operative Chemoradiotherapy +/- Panitumumab (Ind #110152) Followed By Consolidation Chemotherapy In Potentially Oper

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Treatment And Assessment Options In Idiopathic Subglottic Stenosis (Isgs)

  • Investigator: Rebecca Howell
  • Posted Date: May 15, 2019
  • Type of Study: Device

• A Phase II Study Of The Selective Braf Kinase Inhibitor Gsk2118436 In Subjects With Advanced Non-Small Cell Lung Cancer And Braf Mutations

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Research In Pulmonary, Critical Care, And Sleep Medicine

  • Investigator: Francis Mccormack
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Phase I Study Of The Non-Receptor Kinase Inhibitor Bosutinib In Combination With Pemetrexed In Patients With Selected Metastatic Solid Tumors.

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Hiv Related Inflammation And Fibrosis Study Testing Telmisartan Vs. No Medication

  • Investigator: Carl Fichtenbaum
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Gog0238

  • Investigator: Thomas Herzog
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• N-Acetylcysteine In The Treatment Of Depressive Symptoms In Youth At High Risk For Bipolar Disorder: A Functional Connectivity Study

  • Investigator: Fabiano Nery
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Double-Blind Trial For Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Placebo For Patients With Tumors Harb

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Prospective Phase II Trial Of Molecular Profiling To Guide Neoadjuvant Therapy For Resectable And Borderline Resectable Adenocarcinoma Of The Pancre

  • Investigator: Syed Ahmad
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• The Effect Of Ocrelizumab On Lymphocytes In Multiple Sclerosis Patients Previously Exposed To Lymphocyte Altering Agents

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase Ib/II Clinical Study Of Bbi608 (Napabucasin) In Combination With Sorafenib Or Bbi503 (Amcasertib) In Combination With Sorafenib In Adult Patie

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase III Trial Of Dose Escalation Radiation Therapy And Standard Androgen Deprivation Therapy With A Gnrh Agonist Vs. Dose Escalated Radiation Therap

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter Phase 3 Randomized, Open-Label Study Of Bosutinib Versus Imatinib In Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogeno

  • Investigator: Zartash Gul
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Stroke Hyperglycemia Insulin Network Effort (Shine) Trial

  • Investigator: Opeolu Adeoye
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II/III Biomarker-Driven Master Protocol For Second Line Therapy Of Squamous Cell Lung Cancer (Screening Step).

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II Study Of Rrx-001 In Platinum Refractory/Resistant Small Cell Lung Cancer, Egfr Tki Resistant Egfr+ T790m Negative Non-Small Cell Lung Cance

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study To Assess The Efficacy And Safety Of Oral Bps-314D-Mr Added-On To Treprosti

  • Investigator: Jean Elwing
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Study Of Adjuvant Ipilimuab Anti-Ctla4 Therapy Versus High-Dose Interferon A-2B For Resected High Risk Melanoma

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Pilot Feasibility Study In The Detection And Monitoring Of Minimal Residual Disease In The Blood Of Patients Undergoing Treatment For High-Grade B

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase IIb Randomized, Double Blind, Comparative Study To Assess The Efficacy, Safety, Tolerability And Inhibition Of Ovulation Of Two Continuous Reg

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Early Intervention In Cognitive Aging

  • Investigator: Robert Krikorian
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Randomized Phase II Study Of Adjuvant Concurrent Radiation And Chemotherapy Versus Radiation Alone In Resected High-Risk Malignant Salivary Gland Tu

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Cohort Study To Evaluate Genetic Predictors For Aromatase Inhibitor Musculoskeletal Symptoms (Aimss)

  • Investigator: Elyse Lower
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II Trial Of Hypofractionated Dose-Escalated Photon Imrt Or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitan

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ucci-Brain-16-01

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• The Glycemia Reduction Approaches In Diabetes: A Comparative Effectiveness Study

  • Investigator: Robert Cohen
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Traditional Versus Early Aggressive Therapy For Multiple Sclerosis (Treat-Ms) Trial

  • Investigator: Elizabeth Dragan
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase III Trial Evaluating The Addition Of Trastuzumab To Trimodality Treatment Of Her2-Overexpressing Esophageal Adenocarcinoma

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase 3 Comparison Of Imo-2125 With Ipilimumab Versus Ipilimumab Alone In Subjects With Anti-Pd-1 Refractory Melanoma

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Multicenter, Double-Blind Phase 2 Study Of Palbociclib Plus Cetuximab Versus Cetuximab For The Treatment Of Human Papillomavirus-Negativ

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Fulvestrant Alone Versus Fulvestrant And Everolimus Versus Fulvestrant, Everolimus And Anastrozole: A Phase III Randomized Placebo-Controlled Trial I

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase II/III Trial Of Radiotherapy With Concurrent Medi4736 (Durvalumab) Vs. Radiotherapy With Concurrent Cetuximab In Patients With Stage

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Research Study For Patients Aged 7 To 17 Years, With Major Depressive Disorder (Mdd)

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase Ib, Open-Label, Dose Escalation Trial Investigating Different Doses And Schedules Of Sym004 In Combination With Platinum-Doublets In Subjects

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Comparison Of Hemorrhagic And Ischemic Strokes Among Blacks And Whites: A Population-Based Study In Greater Cincinnati, Ohio

  • Investigator: Brett Kissela
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Genetic Analysis Of Preterm Birth

  • Investigator: Emily Defranco
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase II/III Randomized Trial Of Veliparib Or Placebo In Combination With Adjuvant Temozolomide In Newly Diagnosed Glioblastoma With Mgmt Promoter

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III, Open-Label, Multicenter, Randomized Study Evaluating The Efficacy And Safety Of Atezolizumab (Mpdl3280a, Anti-Pd-L1 Antibody) In Combinat

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II Randomized Study Of Rituximab, Methotrexate, Procarbazine, Vincristine, And Cytarabine With And Without Low-Dose Whole-Brain Radiotherapy For

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase II Trial For Patients With P16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• An Investigation Of Dek And Associated Molecular Markers In Breast Cancer

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Anemia In End Stage Renal Disease Study Testing And Investigational Drug Daprodustat Anemia Pill Vs. The Standard Of Care (Aranesp) Injections.

  • Investigator: Shashi Kant
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Mallinckrodt Treatment Of Proteinuria Due To Idiopathic Focal Segmental Glomerulosclerosis With Ho Acthar Gel

  • Investigator: Shashi Kant
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study Of Hsp90 Inhibitor At13387 Alone And In Combination With Crizotinib In The Treatment Of Non-Small Cell Lung Cancer (Nsclc)

  • Investigator: Nagla Abdel Karim
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Phase III Study Of Sorafenib Versus Stereotatic Body Radiation Therapy Followed By Sorafenib In Hepatocellular Carcinoma

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Phase II Trial Of Intermittent Versus Continuous Dosing Of Dabrafenib (Nsc-763760) And Trametinib (Nsc-763093) In Brafv600e/K Mutant Mel

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• The Primary Goal Of This Project Is To Determine The Effects Of 6-Week Dietary Supplementation With One Of Two Doses Of Citicoline (250 Mg/D, 500 Mg/D

  • Investigator: Robert Mcnamara
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1A

  • Investigator: Joseph Nicolas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Age Related Study For Breast Cancer Survivors Comparing Treatment For Painful Intercourse.

  • Investigator: James Whiteside
  • Posted Date: May 15, 2019
  • Type of Study: Device

• A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy And Radiation Therapy Alone For Women With Her2- Positive D

  • Investigator: Elizabeth Shaughnessy
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• High-Intensity Interval Training In Chronic Stroke

  • Investigator: Kari Dunning
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Language Recovery In Aphasic Acute Ischemic Stroke Patients

  • Investigator: Elisheva Coleman
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Neurofunctional Predictors Of Escitalopram Treatment Response In Adolescents With Anxiety

  • Investigator: Jeffrey Strawn
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 1B, Open Label Study Of Dalantercept Plus Sorafenib In Patients With Advanced Hepatocellular Carcinoma

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Double-Blinded, Placebo-Controlled Phase II Study Of Adjuvant Everolimus Following The Resection Of Metastatic Pancreatic Neuroendocrine

  • Investigator: Shimul Shah
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Fty720 (Fingolimod)

  • Investigator: Aram Zabeti
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Gemcitabine/Abraxane Chemotherapy And Dose Escalated Radiotherapy For Locally Advanced, Unresectable Pancreatic Cancer

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Prospective Pilot Study To Evaluate The Feasibility Of Intensity Modulated Proton Therapy In Reducing Toxicity In Anal Cancer

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Comparing Observation Versus Radiation For Newly Diagnosed Grade II Meningiomas That Have Been Completely Removed Through Surgery

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A011401

  • Investigator: Neetu Radhakrishnan
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Study Of Exenatide For Weight Gain Associated With Olanzapine.

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase I/ II Study Of Chemo Radiation Plus The Anti-Pd-1 Antibody, Pembrolizumab (Mk-3475) For Locally Advanced Laryngeal Squamous Cell Carcinoma

  • Investigator: Vinita Takiar
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 2/3, Multi-Center, Open-Label, Randomized Study Of Weekly Nab?- Paclitaxel In Combination With Gemcitabine Or Carboplatin, Compared To Gemcita

  • Investigator: Mahmoud Charif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Zoloft And/Or Psychotherapy Study For Children And Adolescents With Anxiety And/Or Depression

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• An Ongoing, 5-Year Post Market Study To Track Clinical Application, Of Decisiondx-Melanoma Gene Expression Profile (Gep) Assay Results And The Impact

  • Investigator: Jeffrey Sussman
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Study Of Oral Sapacitabine In Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Clinical Efficacy And Safety Of Subcutaneous Administration Of An Investigational Drug In The Prophylactic Treatment Of Heredita

  • Investigator: Jonathan Bernstein
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Neuroimaging Study For Children And Adolescents With Adhd

  • Investigator: Melissa Delbello
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase I Dose-Finding Study Of Metformin In Combination With Concurrent Cisplatin And Radiation In Patients With Locally Advanced Head And Neck Squam

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Do You Have Depression And Have Tried Antidepressant Medication?

  • Investigator: Lesley Arnold
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized, Placebo-Controlled, Parallel Group Study To Evaluate The Effect Of Amifampridine Phosphate In Patients With Musk Antibody Positive Myast

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Trial Of 6 Versus 12 Treatments Of Adjuvant Folfox Plus Celecoxib Or Placebo For Patients With Resected Stage III Colon Cancer.

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II/III Trial Of Neoadjuvant Folfox, With Selective Use Of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiatio

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Maternal Outcomes And Neurodevelopmental Effects Of Antiepileptic Drugs (Monead)

  • Investigator: Jennifer Cavitt
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Ethnic/Racial Variations Of Intracerebral Hemorrhage

  • Investigator: Daniel Woo
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study Of The Efficacy, Safety, And Tolerability Of Oral Full-Spectrum Microbiot

  • Investigator: Bruce Yacyshyn
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Cervical Diverticulum Prospective, Multi-Institutional Study Proposal

  • Investigator: Rebecca Howell
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase 1/2, Open-Label Randomized Study Of Ulocuplumab (Bms-936564) In Combination With Low Dose Cytarabine In Subjects With Newly Diagnosed Acute My

  • Investigator: Zartash Gul
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Patient Assisted Intervention For Neuropathy: Comparison Of Treatment In Real Life Situations (Pain-Controls)

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Feasibility Trial Of The Modified Atkins Diet And Bevacizumab For Recurrent Glioblastoma

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Identification Of A Plasma Proteomic Signature For Lung Cancer

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ohio Brain Tumor Study

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase I, Open-Label, Multiple-Ascending Dose Trial To Investigate The Safety, Tolerability, Pharmacokinetics, Biological And Clinical Activity Of Ms

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II Trial Of Post-Operative Or Definitive Concurrent Radiation And Cetuximab For Locally Advanced Cutaneous Squamous Cell Carcinoma Of The Head

  • Investigator: Vinita Takiar
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study Of Arn-509 In Men With Non-Metastatic (M0) Castration-Resistant Prostate

  • Investigator: R. Bruce Bracken
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Clinical Trial Evaluating Dcvax?-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multifor

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study To Evaluate The Safety And Effectiveness Of Evicel? Fibrin Sealant Compared To A Hydrogel Sealant For Sutured Dural Repair

  • Investigator: Norberto Andaluz
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• An Open-Label, Non-Randomised, Multicentre Study To Allow Continued Access To And Assess The Safety And Tolerability Of Azd1775 For Patients Enrolled

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase II Study Of Temozolomide Or Temozolomide And Capecitabine In Patients With Advanced Pancreatic Neuroendocrine Tumors

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase III Study Of Mfolfox6/Bevacizumab Combination Chemotherapy With Or Without Atezolizumab Or Atezolizumab Monotherapy In The First-Li

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Assessment Of Dha On Reducing Early Preterm Birth

  • Investigator: Emily Defranco
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small

  • Investigator: Sandra Starnes
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized Trial Of Blinatumomab For Newly Diagnosed Bcr-Abl Negative B Lineage Acute Lymphoblastic Leukemia In Adults

  • Investigator: Stephen Medlin
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Long Term Safety Study Of Amifampridine Phosphate In Patients With Musk Antibody Positive And Achr Antibody Positive Myasthenia Gravis Patients

  • Investigator: Hani Kushlaf
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase II Study Of Perioperative Mfolfirinox Versus Gemcitabine/Nab-Paclitaxel As Therapy For Resectable Pancreatic Adenocarcinoma.

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Ea2142

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Bxq-350- A Phase 1, Dose-Escalation, Open-Label, Safety And Pharmacokinetic, First In Human Study Of Bxq-350 Administered As A Single Agent By Intrave

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Ttudy To Evaluate The Safety And Efficacy Of The Deep Transcranial Magnetic Stimulation (Dtms) Intended As An Aid To Smoking Cessation

  • Investigator: Leah Casuto
  • Posted Date: May 15, 2019
  • Type of Study: Device

• An Open-Label, Phase 1B/2 Study Investigating Recommended Phase 2 Dose, Safety, Tolerability, And Preliminary Efficacy Of Tak-659 In Adult Patients Wi

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial Of Salvage Radiotherapy With Or Without Enhanced Anti-Androgen Therapy With Apalutamid

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Double-Blind, Randomized, Two Arm Phase 2 Study Of Nivolumab In Combination With Ipilimumab Versus Nivolumab In Combination With Ipilimumab Placebo

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Pragmatic Phase III Randomized Trial Of Proton Vs. Photon Therapy For Patients With Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiati

  • Investigator: Teresa Meier
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Study To Evaluate The Effect Of Isotretinoin On Immune Activation In Hiv With Lower Cd4+ T Cell Counts On Suppressive Antiretroviral Treatment

  • Investigator: Carl Fichtenbaum
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Everest: Everolimus For Renal Cancer Ensuing Surgical Therapy, A Phase III Study

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Multicenter Clinical Study Of The Sonablate? 450 (Sonablate) For The Treatment Of Locally Recurrent Prostate Cancer With Hifu

  • Investigator: James Donovan
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Randomized Double Blind Placebo Controlled Study Of Erlotinib Or Placebo In Patients With Completely Resected Epidermal Growth Factor Receptor (Egfr)

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall And Regional Nodal Xrt And Post-Lumpectomy Regional Nodal Xrt In Patients

  • Investigator: Jordan Kharofa
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Fat Around The Heart As An Indication Of Inflammation In The Blood In Those With And Without Coronary Artery Disease And Those With And Without Hiv In

  • Investigator: David Harris
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Of Oral Rpc1063 As Induction And Maintenance Therapy For Moderate To Severe

  • Investigator: Bruce Yacyshyn
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Inflammation Biomarkers And Treatment Outcome In Complex Regional Pain Syndrome

  • Investigator: Harsh Sachdeva
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Nsmm-5001

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Phase II Randomized Placebo-Controlled Trial Of Cisplatin With Or Without Abt-888 (Veliparib) In Metastatic Triple-Negative Breast Cancer And/Or Brca

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Study Of The Contraceptive Efficacy, Safety And Tolerability Of The Ag200-15 Transdermal Contraceptive Delivery System (Birth Control Patch).

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study To Evaluate The Safety And Efficacy Of Estradiol In Combination With Proge

  • Investigator: Michael Thomas
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Post Market Surveillance Study Of The Wingspan? Stent System With Gateway? Percutaneous Transluminal Angioplasty (Pta) Balloon Catheter, Also Known

  • Investigator: Andrew Ringer
  • Posted Date: May 15, 2019
  • Type of Study: Observational/Survey

• Roxadustat For Anemia In Esrd On Dialysis At Dci Clinics

  • Investigator: Suresh Kamath
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Randomized Double-Blind Phase III Study Of Ibrutinib During And Following Autologous Stem Cell Transplantation Versus Placebo In Patients With Relap

  • Investigator: Tahir Latif
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase 3 Trial Of Pembrolizumab (Mk-3475) Vs Standard Treatment In Recurrent/Metastatic Head And Neck Cancer

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating The Use Of Adjuvant Endocrine Therapy +/- One Year Of Everolimus In Patients With H

  • Investigator: John Morris
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Eliosmetastatic

  • Investigator: Rekha Chaudhary
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Phase III Randomized, Double Blind Trial Of Chemoembolization With Or Without Sorafenib In Unresectable Hepatocellular Carcinoma (Hcc) In Patients W

  • Investigator: Olugbenga Olowokure
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• A Single Arm Phase 2 Study Of Adjuvant Nivolumab After Salvage Resection In Head And Neck Squamous Cell Carcinoma Patients Previously Treated With Definitive Therapy

  • Investigator: Trisha Wise-Draper
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• Phase II Double-Blinded Placebo-Controlled Study Of Bevacizumab With Or Without Amg 386 In Patients With Recurrent Glioblastoma Or Gliosarcoma.

  • Investigator: Kevin Redmond
  • Posted Date: May 15, 2019
  • Type of Study: Drug

• The Milo Study (Mek Inhibitor In Low-Grade Serous Ovarian Cancer): A Multinational, Randomized, Open-Label Phase 3 Study Of Mek162 Vs. Physician’S Choice Of Chemotherapy In Patients With Recurrent Or Persistent Low-Grade Serous Carcinomas Of The Ovary, Fallopian Tube Or Primary Peritoneum

  • Investigator: Eric Eisenhauer
  • Posted Date: Mar 10, 2014
  • Type of Study: Drug